27
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene

, , , , , & show all
Pages 236-249 | Published online: 29 Sep 2008

References

  • ARAND, M., MÜHLBAUER, R., HENGSTLER, J., JAGER, E., FUCHS, J., WINKLER, L. and OESCH, E 1996, A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry, 236, 184–186.
  • FERNANDEZ, J. G. and CAPEROS, J. R. 1977, Styrene exposure. An experimental study of pulmonary absorption and excretion. International Archives of Occupational and Environmental Health, 40, 1–12.
  • FRITSCHE, E., PITTMAN, G. S. and BELL, D. A. 2000, Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutation Research Genomics, 432, 1–5.
  • GHITTORI, S., MAESTRI, L., IMBRIANI, M., CAPODAGLIO, E. and CAVALLERI, A. 1997, Urinary excretion of specific mercapturic acids in workers exposed to styrene. American Journal of Industrial Medicine, 31, 636–644.
  • GUENGERICH, E P, Kim, D. H. and IwAsAxi, M. 1991, Role of human cytochrome P-450 11E1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168–179.
  • HASSETT, C., AICHER, L., SIDHU, J. S. and OMIECINSKY, C.J. 1994, Human microsomal epoxide hydrolase : genetic polymorphism and functional expression in vitro of amino acid variants. Human Molecular Genetics, 3,421–428.
  • HAUFROID, V., CLIPPE, A., KNOOPS, B., BERNARD, A. and LISON, D. 1998, Genotyping in urine: an interesting tool for epidemiological studies. Clinical Chemistry, 44, 2210–2211.
  • HAUFROID, V., GARDINAL, S., LICOT, C., VILLALPANDO, M. L., VAN OBBERGH, L., CLIPPE, A. and LISON, D. 2000, Biological monitoring of exposure to sevofiurane in operating room personnel by the measurement of hexafiuoroisopropanol and fluoride in urine. Biomarkers, 5, 141–151.
  • Hu, Y., HAKKOLA, J., OSCARSON, M. and INGELMAN-SUNDBERG, M. 1999, Structural and functional characterization of the 5'-fianking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochemical and Biophysical Research Communications, 263, 286-2 93.
  • Kim, R. B., O'SHEA, D. O. and WILKINSON, G. R. 1995, Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clinical Pharmacology and Therapeutics, 57, 645–654.
  • Kim, H., WANG, R. S., ELOVAARA, E., RAUNIO, H., PELKONEN, O., AOYAMA, T., VAINIO, H. and NAKAJIMA, T. 1997, Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica, 27, 657–665.
  • LAMBERT, B., BASTLOVA, T., OSTERHOLM, A. M. and Hou, S. M. 1995, Analysis of mutation at the hprt locus in human T lymphocytes. Toxicology Bette's, 82–83, 323–333.
  • LANCASTER, J. M., BROWNLEE, H. A., BELL, D. A., FUTREAL, P. A., MARKS, J. R., BERCHUCK, A., WISEMAN, R. W. and TAYLOR, J. A. 1996, Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Molecular Carcinogenesis,17, 160–162.
  • LIEBER, C. S. 1997, Cytochrome P-4502E1: Its physiological and pathological role. Physiological Reviews, 77, 517–544.
  • LUCAS, D., FERRARA, R., GONZALEZ, E., BODENEZ, P, ALBOREZ, A., MANNO, M. and BERTHOU, E 1999, Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics, 9, 377–388.
  • MCBRIDE, O. W., UMENO, M., GELBOIN, H. V. and GONZALEZ, E J. 1987, A Tact I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Research, 15, 10071.
  • MCCARVER, D. G., BYUN, R., HINES, R. N., HICHME, M. and WEGENEK, W. 1998, A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicology and Applied Pharmacology, 152, 276–281.
  • NAKAJIMA, T., ELOVAARA, E., GONZALEZ, E J., GELBOIN, H. V., VAINIO, H. and AOYAMA, T. 1993, Butadiene and Styrene: Assessment of Health Hazards. IARC Scientific Publication, 127 (Lyon: IARC), pp. 101–108.
  • NAKAJIMA, T., ELOVAARA, E., GONZALEZ, E J., GELBOIN, H. V., RAUNIO, H., PELKONEN, O., VAINIO, H. and AOYAMA, T. 1994, Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chemical Research in Toxicology, 7, 891–896.
  • OLLIKAINEN, T., HIRVONEN, A. and NORPPA, H. 1998, Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environmental and Molecular Mutagenesis, 31, 311–315.
  • PEMBLE, S., SCHROEDER, K. R., SPENCER, S. R., MEYER, D. J., HALLIER, E., BOLT, H. M., KETTERER, B. and TAYLOR, J. B. 1994, Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical Journal, 300, 271–276.
  • RANNUG, A., ALEXANDRIE, A.-K., PERSSON, I. and INGELMAN-SUNDBERG, M. 1995, Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance. Journal of Occupational and Environmental Medicine, 37, 25–36.
  • STREETMAN, D. S., BERTINO, JR J. S. and NAFZIGER, A.N. 2000, Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics, 10, 187–216.
  • UEMATSU, E, KIKUCHI, H., OHMACHI, T., SAGAMI, I., MOTOMIYA, M., KAMATAKI, T., KOMORI, M. and WATANABE, M. 1991, Two common RFLPs of the human CYP2E gene. Nucleic Acids Research, 19, 2803.
  • UUSKULA, M., JARVENTAUS, H., HIRVONEN, A., SORSA, M. and NORPPA, H. 1995, Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2 -epoxy-3 -butene in cultured human lymphocytes. Carcinogenesis, 16, 947–950.
  • WATANABE, J., HAYASHI, S. I., NAKACHI, K., Imm, K., SUDA, Y., SEKINE, T. and KAWAJIRI, K. 1990, PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Research, 18,7194.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.